142
Views
26
CrossRef citations to date
0
Altmetric
Original Article

Reduced bone mass and increased bone turnover in postmenopausal women with epilepsy using antiepileptic drug monotherapy

, , , , , & show all
Pages 759-766 | Received 13 Mar 2008, Accepted 21 May 2008, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Barbara Miziak, Barbara Błaszczyk, Magdalena Chrościńska-Krawczyk, Grzegorz Danilkiewicz, Ewa Jagiełło-Wójtowicz & Stanisław J Czuczwar. (2014) The problem of osteoporosis in epileptic patients taking antiepileptic drugs. Expert Opinion on Drug Safety 13:7, pages 935-946.
Read now
Karl O Nakken & Erik Taubøll. (2010) Bone loss associated with use of antiepileptic drugs. Expert Opinion on Drug Safety 9:4, pages 561-571.
Read now

Articles from other publishers (24)

Pawel Szulc, Douglas C. Bauer & Richard Eastell. 2021. Marcus and Feldman's Osteoporosis. Marcus and Feldman's Osteoporosis 1545 1588 .
Valentina Camozzi. 2020. Male Osteoporosis. Male Osteoporosis 117 130 .
Sarah Seberg Diemar, Anne-Sophie Sejling, Pia Eiken, Noémi Becser Andersen & Niklas Rye Jørgensen. (2019) An explorative literature review of the multifactorial causes of osteoporosis in epilepsy. Epilepsy & Behavior 100, pages 106511.
Crossref
Rhys D. Brady, Ker Rui Wong, Dale L. Robinson, Richelle Mychasiuk, Stuart J. McDonald, Ryan A. D’Cunha, Glenn R. Yamakawa, Mujun Sun, John D. Wark, Peter Vee Sin Lee, Terence J. O’Brien, Pablo M. Casillas-Espinosa & Sandy R. Shultz. (2019) Bone Health in Rats With Temporal Lobe Epilepsy in the Absence of Anti-Epileptic Drugs. Frontiers in Pharmacology 10.
Crossref
Bushra Parveen, Ambrish Kumar Tiwari, Moon Jain, Subhashis Pal, Naibedya Chattopadhyay, Manjari Tripathi & Divya Vohora. (2018) The anti-epileptic drugs valproate, carbamazepine and levetiracetam cause bone loss and modulate Wnt inhibitors in normal and ovariectomised rats. Bone 113, pages 57-67.
Crossref
P. Szulc, K. Naylor, N. R. Hoyle, R. Eastell & E. T. Leary. (2017) Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability. Osteoporosis International 28:9, pages 2541-2556.
Crossref
Sandra J. Petty, Helen Wilding & John D. Wark. (2016) Osteoporosis Associated with Epilepsy and the Use of Anti-Epileptics—a Review. Current Osteoporosis Reports 14:2, pages 54-65.
Crossref
Keshav Panday, Amitha Gona & Mary Beth Humphrey. (2014) Medication-induced osteoporosis: screening and treatment strategies. Therapeutic Advances in Musculoskeletal Disease 6:5, pages 185-202.
Crossref
Arne Reimers. (2014) New antiepileptic drugs and women. Seizure 23:8, pages 585-591.
Crossref
Jean-Pascal Roussy, Louis Bessette, Sasha Bernatsky, Elham Rahme & Jean Lachaine. (2014) Rates of Non-vertebral Osteoporotic Fractures in Rheumatoid Arthritis and Postfracture Osteoporosis Care in a Period of Evolving Clinical Practice Guidelines. Calcified Tissue International 95:1, pages 8-18.
Crossref
K. Beerhorst, I. Y. Tan, M. De Krom, P. Verschuure & A. P. Aldenkamp. (2013) Antiepileptic drugs and high prevalence of low bone mineral density in a group of inpatients with chronic epilepsy. Acta Neurologica Scandinavica 128:4, pages 273-280.
Crossref
Diane M. Biskobing. 2013. Osteoporosis. Osteoporosis 93 107 .
Pawel Szulc & Douglas C. Bauer. 2013. Osteoporosis. Osteoporosis 1573 1610 .
Richard Lee, Kenneth Lyles, Richard Sloane & Cathleen Colón-Emeric. (2012) The association of newer anticonvulsant medications and bone mineral density. Endocrine Practice:aop, pages 1-22.
Crossref
K. Beerhorst, F. M. Schouwenaars, I. Y. Tan & A. P. Aldenkamp. (2012) Epilepsy: fractures and the role of cumulative antiepileptic drug load. Acta Neurologica Scandinavica 125:1, pages 54-59.
Crossref
TorbjÖrn. Tomson & Bernhard J. Steinhoff. 2012. Epilepsy. Epilepsy 683 698 .
S. Svalheim, L. S. Røste, K. O. Nakken & E. Taubøll. (2011) Bone health in adults with epilepsy. Acta Neurologica Scandinavica 124, pages 89-95.
Crossref
D. J. Betteridge. (2011) Thiazolidinediones and fracture risk in patients with Type 2 diabetes. Diabetic Medicine 28:7, pages 759-771.
Crossref
Karine Briot. (2011) Effets osseux des antiépileptiques. Revue du Rhumatisme Monographies 78:2, pages 94-97.
Crossref
M. Bacher, C. Kurth & B.J. Steinhoff. (2011) 25-Hydroxyvitamin-D-Spiegel bei antikonvulsiver Dauermedikation25-Hydroxyvitamin D levels in chronic anticonvulsant therapy. Zeitschrift für Epileptologie 24:1, pages 40-44.
Crossref
Andrew P Hearn & Eli Silber. (2010) Osteoporosis in multiple sclerosis. Multiple Sclerosis Journal 16:9, pages 1031-1043.
Crossref
. (2010) Current World Literature. Current Opinion in Neurology 23:2, pages 194-201.
Crossref
Richard H. Lee, Kenneth W. Lyles & Cathleen Colón-Emeric. (2010) A review of the effect of anticonvulsant medications on bone mineral density and fracture risk. The American Journal of Geriatric Pharmacotherapy 8:1, pages 34-46.
Crossref
Nasir Mirza, Anthony G. Marson & Munir Pirmohamed. (2009) Effect of topiramate on acid-base balance: extent, mechanism and effects. British Journal of Clinical Pharmacology 68:5, pages 655-661.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.